Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-16 7:15 pm Purchase | 13G | BRIDGEBIO PHARMA INC BBIO | Kumar Neil | 9,959,504 5.59% | 135,596 (+1.38%) | View |
| 2024-02-13 5:00 pm Purchase | 13G | BRIDGEBIO PHARMA INC BBIO | VANGUARD GROUP INC | 12,800,294 7.36% | 2,208,839 (+20.85%) | View |
| 2024-01-29 5:25 pm Purchase | 13G | BRIDGEBIO PHARMA INC BBIO | BlackRock Inc. BLK | 10,156,773 5.8% | 322,372 (+3.28%) | View |
| 2024-01-23 10:16 am Sale | 13G | BRIDGEBIO PHARMA INC BBIO | STATE STREET CORP STT | 5,086,899 2.92% | -3,758,044 (-42.49%) | View |
| 2023-11-22 4:15 pm Unchanged | 13D | BRIDGEBIO PHARMA INC BBIO | VIKING GLOBAL INVESTORS LP | 25,120,991 15.7% | 0 (Unchanged) | View |
| 2023-07-19 9:52 pm Sale | 13D | BRIDGEBIO PHARMA INC BBIO | VIKING GLOBAL INVESTORS LP | 25,120,991 15.7% | -1,500,000 (-5.63%) | View |
| 2023-02-14 4:18 pm Purchase | 13G | BRIDGEBIO PHARMA INC BBIO | Kumar Neil | 9,823,908 6.42% | 820,697 (+9.12%) | View |
| 2023-02-09 11:12 am Purchase | 13G | BRIDGEBIO PHARMA INC BBIO | VANGUARD GROUP INC | 10,591,455 7.09% | 1,259,772 (+13.50%) | View |
| 2023-02-08 10:30 am Purchase | 13G | BRIDGEBIO PHARMA INC BBIO | STATE STREET CORP STT | 8,844,943 5.92% | 8,844,943 (New Position) | View |
| 2023-01-31 5:52 pm Purchase | 13G | BRIDGEBIO PHARMA INC BBIO | BlackRock Inc. BLK | 9,834,401 6.6% | 558,811 (+6.02%) | View |
| 2022-02-14 9:01 pm Purchase | 13G | BRIDGEBIO PHARMA INC BBIO | PERCEPTIVE ADVISORS LLC | 7,128,755 4.8% | 422,487 (+6.30%) | View |
| 2022-02-14 4:50 pm Purchase | 13G | BRIDGEBIO PHARMA INC BBIO | Kumar Neil | 9,003,211 6.05% | 672,614 (+8.07%) | View |
| 2022-02-09 3:33 pm Purchase | 13G | BRIDGEBIO PHARMA INC BBIO | VANGUARD GROUP INC | 9,331,683 6.34% | 2,890,371 (+44.87%) | View |
| 2022-02-03 4:41 pm Purchase | 13G | BRIDGEBIO PHARMA INC BBIO | BlackRock Inc. BLK | 9,275,590 6.3% | 2,758,046 (+42.32%) | View |
| 2021-02-17 5:28 pm Sale | 13D | BRIDGEBIO PHARMA INC BBIO | KKR Genetic Disorder L.P. | 31,060,971 20.9% | -3,450,000 (-10.00%) | View |
| 2021-02-16 5:02 pm Sale | 13G | BRIDGEBIO PHARMA INC BBIO | Kumar Neil | 8,330,597 6.74% | -288,186 (-3.34%) | View |
| 2021-02-16 3:36 pm Unchanged | 13G | BRIDGEBIO PHARMA INC BBIO | PERCEPTIVE ADVISORS LLC | 6,706,268 5.5% | 0 (Unchanged) | View |
| 2021-02-12 7:33 pm Sale | 13G | BRIDGEBIO PHARMA INC BBIO | AMERICAN INTERNATIONAL GROUP INC. AIG | 3,381,412 2.8% | -3,383,180 (-50.01%) | View |
| 2021-02-10 10:39 am Purchase | 13G | BRIDGEBIO PHARMA INC BBIO | VANGUARD GROUP INC | 6,441,312 5.25% | 6,441,312 (New Position) | View |
| 2021-02-05 07:51 am Purchase | 13G | BRIDGEBIO PHARMA INC BBIO | BlackRock Inc. BLK | 6,517,544 5.3% | 6,517,544 (New Position) | View |